Business

HLS Therapeutics to Host Q1 2020 Financial Results Conference Call

HLS Therapeutics to Host Q1 2020 Financial Results Conference Call Canada NewsWire...

articleHls Therapeutics, Inc.April 30, 20204/company/hls-therapeutics-inc/news/hls-therapeutics-to-host-q1-2020-financial-results-conference-call
HLS Therapeutics to Host Q1 2020 Financial Results Conference Call

About this update from Hls Therapeutics, Inc.

[{"type":"text","content":"\n\n\n\nHLS Therapeutics to Host Q1 2020 Financial Results Conference Call\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen3{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; TEXT-ALIGN: LEFT; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, April 30, 2020\n\n\n\nTORONTO, April 30, 2020 /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS), announces that it will release its Q1 2020 financial results by press release at 6:30 a.m. Eastern Time on Thursday, May 7, 2020. The Company will hold a conference call that same day at 8:30 a.m. Eastern Time to discuss its results. The call will be hosted by Mr. Greg Gubitz, Chief Executive Officer, Mr. Gilbert Godin, President and Chief Operating Officer and Mr. Tim Hendrickson, Chief Financial Officer. To participate on the call, please enter a dial-in number below and then enter the Conference ID when prompted.\nCONFERENCE ID:\n6457646\nDATE:\nThursday, May 7, 2020\nTIME:\n8:30 a.m. Eastern Time\nDIAL-IN NUMBER: \n1-877-267-7318 or 631-485-5848\nWEBCAST LINK:\nhttps://produceredition.webcasts.com/starthere.jspei=1311902&tp_key=59c36737e9 \nTAPED REPLAY:\n1-855-859-2056 or 404-537-3406\nREPLAY CODE:\n6457646\n \nThe taped replay will be available for 14 days and the archived webcast will be available for 90 days. \nA link to the live audio webcast of the conference call will also be available on the events page of the investors section of HLS Therapeutics' website at www.hlstherapeutics.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to hear the webcast. \nABOUT HLS THERAPEUTI...

More updates from Hls Therapeutics, Inc.